Teva and Active Biotech to Initiate Pivotal Phase III Trial ...
PharmaLive.com (press release) - Newtown,PA,USA
"Laquinimod has the potential to be a novel, orally-administered disease modifying treatment for people suffering from multiple sclerosis," said Sven ...
See all stories on this topic